UnitedHealth Stock Slides -13% With A 7-Day Losing Spree
UnitedHealth (UNH) stock hit day 7 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -13% return. The company has lost about $42 Bil in value over the last 7 days, with its current market capitalization at about $291 Bil. The stock remains 35.3% below its value at the end of 2024. This compares with year-to-date returns of 14.3% for the S&P 500.
UNH provides diversified health care services, including consumer health benefit plans for various employers and individuals, and pharmacy care services like retail, home delivery, specialty, and clinical programs. Is this drop a warning sign or a setup for rebound? Deep dive with Buy or Sell UNH.
A single stock can be risky, but there is a huge value to a broader, diversified approach we take with the Trefis High Quality Portfolio. Trefis works with Empirical Asset Management — a Boston area wealth manager — whose asset allocation strategies yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Empirical has incorporated the Trefis HQ Portfolio in this asset allocation framework to provide clients with higher returns while taking on lower levels of risk versus the benchmark index.
Comparing UNH Stock Returns With The S&P 500
The following table summarizes the return for UNH stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | UNH | S&P 500 |
|---|---|---|
| 1D | -1.9% | -1.1% |
| 7D (Current Streak) | -12.6% | -2.5% |
| 1M (21D) | -13.1% | -0.5% |
| 3M (63D) | 29.0% | 5.2% |
| YTD 2025 | -35.3% | 14.3% |
| 2024 | -2.4% | 23.3% |
| 2023 | 0.8% | 24.2% |
| 2022 | 6.9% | -19.4% |
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact. Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: UNH Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 35 S&P constituents with 3 days or more of consecutive gains and 61 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 23 | 20 |
| 4D | 8 | 28 |
| 5D | 1 | 5 |
| 6D | 3 | 2 |
| 7D or more | 0 | 6 |
| Total >=3 D | 35 | 61 |
Key Financials for UnitedHealth (UNH)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $371.6 Bil | $400.3 Bil |
| Operating Income | $32.4 Bil | $32.3 Bil |
| Net Income | $22.4 Bil | $14.4 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $111.6 Bil | $113.2 Bil |
| Operating Income | $5.2 Bil | $4.3 Bil |
| Net Income | $3.4 Bil | $2.3 Bil |
The losing streak UNH stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.